Neuronal PET tracers for Alzheimer's disease

Area of Science:

• Neurology
• Radiology
• Biochemistry

Background:

• Alzheimer's disease (AD) diagnosis and progression monitoring remain challenging.
• Brain imaging techniques are crucial for understanding AD pathology.
• Neurofibrillary tau aggregates are key pathological hallmarks of AD.

Purpose of the Study:

• To review recent advancements in PET tracers for detecting Alzheimer's disease (AD) tau pathology.
• To discuss the clinical implementation of established and novel PET imaging tracers for AD.
• To highlight the importance and challenges of PET radiotracers in AD imaging.

Main Methods:

• Literature review of recent studies on PET tracers for Alzheimer's disease.
• Analysis of investigational PET tracers targeting neurofibrillary tau aggregates.
• Discussion of clinical applications and challenges in PET imaging for AD.

Main Results:

• Several new PET tracers show promise for visualizing tau aggregates in Alzheimer's disease.
• Established and newer generation PET tracers are being evaluated for clinical use.
• PET imaging provides valuable insights into AD progression and therapeutic monitoring.

Conclusions:

• PET imaging, particularly with novel tau-targeting tracers, is a vital tool for advancing Alzheimer's disease research and diagnosis.
• Understanding the capabilities and limitations of different PET tracers is essential for effective clinical implementation.
• Continued development of PET radiotracers is critical for improving Alzheimer's disease management.